Intern Med

1. SHIDA R, Iwakura T, Ohashi N, Ema C, et al
   Anti-contactin 1 Antibody-associated Membranous Nephropathy in Chronic Inflammatory Demyelinating Polyneuropathy with Several Autoantibodies.
   Intern Med. 2024;63:699-705.
   

   >> Share

   
   
2. SUZUKI K, Aizawa M, Tamazawa K, Ueda K, et al
   Relapse of Ulcerative Colitis with Immune Thrombocytopenia and Pyoderma Gangrenosum Subsequent to Receiving COVID-19 Vaccination.
   Intern Med. 2024;63:665-669.
   

   >> Share

   
   
3. MIKI H, Tsuboi H, Kawashima F, Sugita T, et al
   Multidrug-resistant IgA Vasculitis with Gastrointestinal Symptoms Successfully Treated with Intravenous Cyclophosphamide and Maintained with Mycophenolate Mofetil.
   Intern Med. 2024;63:743-747.
   

   >> Share

   
   
4. MURAKAMI T, Kishi M, Tokuda N, Honda M, et al
   Repeated Acute Exacerbations of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Accompanied by Pain and Swelling in Distal Extremities.
   Intern Med. 2024;63:733-737.
   

   >> Share

   
   
5. ISOMURA Y, Tamiya H
   Alectinib-induced Hemolytic Anemia with Positive Direct Antiglobulin Test in a Patient with Lung Adenocarcinoma: A Possible Drug-drug Interaction Effect.
   Intern Med. 2024;63:711-715.
   

   >> Share

   
   
6. YAMAJI S, Kamezaki K, Shinchi M, Takizawa K, et al
   Cardiac Tamponade as an Initial Manifestation of Diffuse Large B-cell Lymphoma One Year after IgG4-related Disease in Remission.
   Intern Med. 2024;63:721-727.
   

   >> Share

   
   
7. KUBO A, Murakami S, Iwata T
   Drug Interaction-induced Hemolytic Anemia: An Unresolved Diagnostic Process.
   Intern Med. 2024;63:631-633.
   

   >> Share

   
   
8. WAKASUGI M, Narita I
   Trends in the Incidence of Renal Replacement Therapy due to Rapidly Progressive Glomerulonephritis in Japan, 2006-2021.
   Intern Med. 2024 Mar 4. doi: 10.2169/internalmedicine.3343.
   

   >> Share

   
   

   
   J Autoimmun

9. CHAVULA T, To S, Smith J, Pedroza M, et al
   CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus.
   J Autoimmun. 2024;145:103197.
   

   >> Share

   
   
10. BONACINI M, Rossi A, Ferrigno I, Muratore F, et al
    miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis.
    J Autoimmun. 2024;144:103186.
    

    >> Share

    
    
11. FISCHER S, Meisinger C, Freuer D
    Autoimmune diseases and female-specific cancer risk: A systematic review and meta-analysis.
    J Autoimmun. 2024;144:103187.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

12. DAYAN CM
    The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease).
    J Clin Endocrinol Metab. 2024 Mar 7:dgad693. doi: 10.1210.
    

    >> Share

    
    

    
    J Neuroimmunol

13. DE ALMEIDA GMR, de Araujo RS, Castrillo BB, Silva GD, et al
    Therapeutic plasma exchange for neuromyelitis optica attacks: Evidence and challenges from a real-world cohort from Brazil.
    J Neuroimmunol. 2024;388:578295.
    

    >> Share

    
    
14. HAHAM N, Zveik O, Rechtman A, Brill L, et al
    Altered immune co-inhibitory receptor expression and correlation of LAG-3 expression to disease severity in NMOSD.
    J Neuroimmunol. 2024;388:578289.
    

    >> Share

    
    
15. KATSU M, Sekine-Tanaka M, Tanaka M, Horai Y, et al
    Inhibition of repulsive guidance molecule-a ameliorates compromised blood-spinal cord barrier integrity associated with neuromyelitis optica in rats.
    J Neuroimmunol. 2024;388:578297.
    

    >> Share

    
    
16. LUO W, Wang X, Kong L, Chen H, et al
    Clinical features and prognosis of Tibetan patients with neuromyelitis optica spectrum disorder are different from those of Han Chinese patients.
    J Neuroimmunol. 2024;388:578263.
    

    >> Share

    
    

    
    J Neurol

17. ZID Y, Robertson NP
    Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials.
    J Neurol. 2024 Mar 4. doi: 10.1007/s00415-024-12273.
    

    >> Share

    
    
18. LI J, Wu X, Chu T, Tan X, et al
    The efficacy and safety of FcRn inhibitors in patients with myasthenia gravis: a systematic review and meta-analysis.
    J Neurol. 2024 Mar 3. doi: 10.1007/s00415-024-12247.
    

    >> Share

    
    
19. GUGER M, Enzinger C, Leutmezer F, Di Pauli F, et al
    Early intensive versus escalation treatment in patients with relapsing-remitting multiple sclerosis in Austria.
    J Neurol. 2024 Mar 2. doi: 10.1007/s00415-024-12256.
    

    >> Share

    
    
20. HECHENBERGER S, Helmlinger B, Tinauer C, Jauk E, et al
    Evaluation of a self-administered iPad((R))-based processing speed assessment for people with multiple sclerosis in a clinical routine setting.
    J Neurol. 2024 Mar 5. doi: 10.1007/s00415-024-12274.
    

    >> Share

    
    
21. HEGEN H, Berek K, Deisenhammer F, Berger T, et al
    Sex impacts treatment decisions in multiple sclerosis.
    J Neurol. 2024 Mar 5. doi: 10.1007/s00415-024-12270.
    

    >> Share

    
    
22. KRIJNEN EA, Broeders TAA, Noteboom S, van Dam M, et al
    The cognitive relevance of non-lesional damage to cortical networks in people with multiple sclerosis.
    J Neurol. 2024 Mar 5. doi: 10.1007/s00415-024-12240.
    

    >> Share

    
    

    
    J Rheumatol

23. PATEL NJ, Wang X, Lin M, Kowalski EN, et al
    Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease.
    J Rheumatol. 2024 Mar 1:jrheum.2023-1092. doi: 10.3899/jrheum.2023-1092.
    

    >> Share

    
    
24. DAWOUD SA, Ahmad NU, Shriver EM, Chung SM, et al
    Orbital and Optic Nerve Sheath Involvement and Pupil-Involving Cranial Nerve 3 Palsy in Giant Cell Arteritis.
    J Rheumatol. 2024 Mar 1:jrheum.2023-1195. doi: 10.3899/jrheum.2023-1195.
    

    >> Share

    
    
25. MORAND EF, Jones SA
    Flare in Systemic Lupus Erythematosus: Lost in Translation?
    J Rheumatol. 2024 Mar 1:jrheum.2024-0122. doi: 10.3899/jrheum.2024-0122.
    

    >> Share

    
    
26. YASUDA N, Yamane T
    Leg Gangrene in Granulomatosis With Polyangiitis.
    J Rheumatol. 2024;51:316-317.
    

    >> Share

    
    
27. FALASINNU T, Nguyen T, Jiang TE, Tamang S, et al
    The Problem of Pain in Rheumatology: Variations in Case Definitions Derived From Chronic Pain Phenotyping Algorithms Using Electronic Health Records.
    J Rheumatol. 2024;51:297-304.
    

    >> Share

    
    
28. YENNEMADI AS, Jordan N, Diong S, Keane J, et al
    The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases.
    J Rheumatol. 2024;51:234-241.
    

    >> Share

    
    

    
    Mult Scler

29. APREA MG, Schiavetti I, Portaccio E, Ballerini C, et al
    Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
    Mult Scler. 2024 Mar 8:13524585241232266. doi: 10.1177/13524585241232266.
    

    >> Share

    
    
30. MONTALBAN X, Piasecka-Stryczynska K, Kuhle J, Benkert P, et al
    Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study.
    Mult Scler. 2024 Mar 4:13524585241234783. doi: 10.1177/13524585241234783.
    

    >> Share

    
    
31. HILLERT J, Bove R, Haddad LB, Hellwig K, et al
    Expert opinion on the use of contraception in people with multiple sclerosis.
    Mult Scler. 2024 Mar 8:13524585241228103. doi: 10.1177/13524585241228103.
    

    >> Share

    
    

    
    N Engl J Med

32. WECHSLER ME, Nair P, Terrier B, Walz B, et al
    Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2024;390:911-921.
    

    >> Share

    
    

    
    Nat Rev Neurol

33. FYFE I
    Mitochondrial DNA marks multiple sclerosis.
    Nat Rev Neurol. 2024 Mar 5. doi: 10.1038/s41582-024-00948.
    

    >> Share

    
    

    
    Neurology

34. OLIVE-CIRERA G, Bruijstens AL, Fonseca EG, Chen LW, et al
    MOG Antibodies Restricted to CSF in Children With Inflammatory CNS Disorders.
    Neurology. 2024;102:e209199.
    

    >> Share

    
    
35. SPELMAN T, Simoneau G, Hyde R, Kuhelj R, et al
    Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study.
    Neurology. 2024;102:e208114.
    

    >> Share

    
    
36. TOGNI CL, Frontzek K, Schubring-Giese M, Imbach LL, et al
    Posttransplant Anti-GABA(A) Receptor Antibody-Associated Autoimmune Encephalitis.
    Neurology. 2024;102:e209245.
    

    >> Share

    
    

    
    PLoS One

37. SMUDJA M, Milenkovic T, Minakovic I, Zdravkovic V, et al
    Self-care activities in pediatric patients with type 1 diabetes mellitus.
    PLoS One. 2024;19:e0300055.
    

    >> Share

    
    
38. TRAN TT, Nguyen TN, Dauvilliers Y, Liblau R, et al
    Absence of specific autoantibodies in patients with narcolepsy type 1 as indicated by an unbiased random peptide-displayed phage screening.
    PLoS One. 2024;19:e0297625.
    

    >> Share

    
    
39. JOZEF M, Locatelli I, Brecl Jakob G, Savsek L, et al
    Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis.
    PLoS One. 2024;19:e0294116.
    

    >> Share

    
    
40. LIU P, Luo J, Zhao L, Fu Q, et al
    Causal relationship between several autoimmune diseases and renal malignancies: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0297861.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

41. YIN R, Melton S, Huseby ES, Kardar M, et al
    How persistent infection overcomes peripheral tolerance mechanisms to cause T cell-mediated autoimmune disease.
    Proc Natl Acad Sci U S A. 2024;121:e2318599121.
    

    >> Share

    
    
42. ANEES F, Montoya DA, Pisetsky DS, Payne CK, et al
    DNA corona on nanoparticles leads to an enhanced immunostimulatory effect with implications for autoimmune diseases.
    Proc Natl Acad Sci U S A. 2024;121:e2319634121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share